Have a personal or library account? Click to login
Bowel-Associated Dermatosis and Arthritis Syndrome (BADAS) – A Literature Review With Diagnostic and Therapeutic Implications and a Report of Two Cases of BADAS Associated With Inflammatory Bowel Disease Cover

Bowel-Associated Dermatosis and Arthritis Syndrome (BADAS) – A Literature Review With Diagnostic and Therapeutic Implications and a Report of Two Cases of BADAS Associated With Inflammatory Bowel Disease

Open Access
|Feb 2026

References

  1. Ahn C, Negus D, Huang W (2018) Pyoderma gangrenosum: A review of pathogenesis and treatment. Expert Rev Clin Immunol 14:225–233. https://doi.org/10.1080/1744666X.2018.1438269
  2. Alshahrani KS, Almohaya AM, Hussein RS et al. (2022) Enthesitis in bowel-associated dermatosis-arthritis syndrome in an ulcerative colitis patient. Case Rep Rheumatol 2022:4556250. https://doi.org/10.1155/2022/4556250
  3. Antonelli E, Bassotti G, Tramontana M et al. (2021) Dermatological manifestations in inflammatory bowel diseases. J Clin Med 10:364. https://doi.org/10.3390/jcm10020364
  4. Aounallah A, Zerriaa S, Ksiaa M et al. (2016) [Bowel-associated dermatosis-arthritis syndrome during ulcerative colitis: A rare extra-intestinal sign of inflammatory bowel disease]. Ann Dermatol Venereol 143:377–381. https://doi.org/10.1016/j.annder.2016.02.009
  5. Aromolo IF, Simeoli D, Maronese CA et al. (2023) The bowel-associated arthritis-dermatosis syndrome (BADAS): A systematic review. Metabolites 13:790. https://doi.org/10.3390/metabo13070790
  6. Ashchyan HJ, Nelson CA, Stephen S et al. (2018) Neutrophilic dermatoses: Pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses. J Am Acad Dermatol 79:1009–1022. https://doi.org/10.1016/j.jaad.2017.11.063
  7. Ashok D, Kiely P (2007) Bowel associated dermatosis - arthritis syndrome: A case report. J Med Case Rep 1:81. https://doi.org/10.1186/1752-1947-1-81
  8. Barland A, Blackmon J, Fraga G et al. (2016) Bowel-associated dermatosis-arthritis syndrome in a patient with Crohn disease. Cutis 97:E1–3.
  9. Caro RDC, Prete MDI, Didona D et al. (2021) Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis. Ital J Dermatol Venereol 156(Suppl. 1):7–8. https://doi.org/10.23736/S2784-8671.19.06198-4
  10. Carubbi F, Ruscitti P, Pantano I et al. (2013) Jejunoileal bypass as the main procedure in the onset of immune-related conditions: The model of BADAS. Expert Rev Clin Immunol 9:441–452. https://doi.org/10.1586/eci.13.26
  11. Chen ST, Song P, Zimarowski MJ et al. (2016) Leg pain and rash in a man with prior bariatric surgery. Int J Dermatol 55:509–511. https://doi.org/10.1111/ijd.12949
  12. Czajkowski R, Lipska P, Watoła W et al. (2023) Bowel-associated dermatosis-arthritis syndrome (BADAS): A narrative review. Postepy Dermatol Alergol 40:355–361. https://doi.org/10.5114/ada.2023.129101
  13. DeFilippis EM, Magro C, Jorizzo JL (2014) Bowel-associated dermatosis - arthritis syndrome in a patient with ulcerative colitis: An extraintestinal manifestation of inflammatory bowel disease. Clin J Gastroenterol 7:410–413. https://doi.org/10.1007/s12328-014-0529-8
  14. Delaney TA, Clay CD, Randell PL (1989) The bowel-associated dermatosis – arthritis syndrome. Australas J Dermatol 30:23–27. https://doi.org/10.1111/j.1440-0960.1989.tb00402.x
  15. Dicken CH (1986) Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass. J Am Acad Dermatol 14:792–796. https://doi.org/10.1016/s0190-9622(86)70095-9
  16. Ely PH (1980) The bowel bypass syndrome: A response to bacterial peptidoglycans. J Am Acad Dermatol 2:473–487. https://doi.org/10.1016/s0190-9622(80)80148-4
  17. Fenske NA, Gern JE, Pierce D, Vasey FB (1983) Vesiculopustular eruption of ulcerative colitis. Arch Dermatol 119:664–669. https://doi.org/10.1001/archderm.1983.01650320038013
  18. Förström L, Winkelmann RK (1977) Acute panniculitis: A clinical and histopathologic study of 34 cases. Arch Dermatol 113:909–917. https://doi.org/10.1001/archderm.1977.01640070043003
  19. Gevers D, Kugathasan S, Denson LA et al. (2014) The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15:382–392. https://doi.org/10.1016/j.chom.2014.02.005
  20. Gubatan J, Moss AC (2018) Vitamin D in inflammatory bowel disease: More than just a supplement. Curr Opin Gastroenterol 34:217–225. https://doi.org/10.1097/MOG.0000000000000449
  21. Guerre-Schmidt AR, Pelletier F, Carbonnel F et al. (2006) [Dermatosis-arthritis syndrome associated with Crohn’s disease in a teenager]. Rev Med Interne 27:874–877. https://doi.org/10.1016/j.revmed.2006.07.017
  22. Hassold N, Jelin G, Palazzo E et al. (2019) Bowel-associated dermatosis arthritis syndrome: A case report with first positron emission tomography analysis. JAAD Case Rep 5:140–143. https://doi.org/10.1016/j.jdcr.2018.10.025
  23. Havele SA, Clark AK, Oboite M et al. (2021) Bowel-associated dermatosis-arthritis syndrome in a child with very early onset inflammatory bowel disease. Pediatr Dermatol 38:697–698. https://doi.org/10.1111/pde.14544
  24. Heard M, Zhang M, Jorizzo JL (2020) A case of bowel-associated dermatosis-arthritis syndrome treated with ustekinumab: The importance of targeting underlying gastrointestinal disease. JAAD Case Rep 6:506–508. https://doi.org/10.1016/j.jdcr.2020.04.001
  25. Hirano A, Umeno J, Okamoto Y et al. (2018) Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis. J Gastroenterol Hepatol 33:1590–1597. https://doi.org/10.1111/jgh.14129
  26. Jockenhöfer F, Wollina U, Salva KA et al. (2019) The PARACELSUS score: A novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol 180:615–620. https://doi.org/10.1111/bjd.16401
  27. Jorizzo JL, Apisarnthanarax P, Subrt P et al. (1983) Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Intern Med 143:457–461. https://doi.org/10.1001/archinte.1983.00350030071013
  28. Jorizzo JL, Schmalstieg FC, Dinehart SM et al. (1984) Bowel-associated dermatosis-arthritis syndrome. Immune complex-mediated vessel damage and increased neutrophil migration. Arch Intern Med 144:738–740. https://doi.org/10.1001/archinte.144.4.738
  29. Keyal U, Liu Y, Bhatta AK (2018) Dermatologic manifestations of inflammatory bowel disease: A review. Discov Med 25: 225–233.
  30. Kinyó Á, Farkas K, Molnár T et al. (2011) Bowel-associated dermatosis-arthritis syndrome – a relapsing, extremely rare extraintestinal sign of acute flare-up in Crohn’s disease. Eur J Dermatol 21:443–445. https://doi.org/10.1684/ejd.2011.1346
  31. Kurtzman D, Vleugels RA, Callen J (2016) Approach to and management of the neutrophilic dermatoses. Curr Dermatol Rep 5:18–29. https://doi.org/10.1007/s13671-016-0129-6
  32. Lacey BW, You D, Speziale A (2011) Pustular skin eruption in a patient with ulcerative colitis. Clin Gastroenterol Hepatol 9:e43–44. https://doi.org/10.1016/j.cgh.2010.11.035
  33. Linares R, Francés R, Gutiérrez A et al. (2021) Bacterial translocation as inflammatory driver in Crohn’s disease. Front Cell Dev Biol 9:703310. https://doi.org/10.3389/fcell.2021.703310
  34. Matheson BK, Gilbertson EO, Eichenfield LF (1996) Vesiculopustular eruption of Crohn’s disease. Pediatric Dermatol 13:127–130. https://doi.org/10.1111/j.1525-1470.1996.tb01418.x
  35. Maverakis E, Marzano AV, Le ST et al. (2020) Pyoderma gangrenosum. Nat Rev Dis Primers 6:81. https://doi.org/10.1038/s41572-020-0213-x
  36. Maverakis E, Ma C, Shinkai K et al. (2018) Diagnostic criteria of ulcerative pyoderma gangrenosum: A delphi consensus of international experts. JAMA Dermatol 154:461–466. https://doi.org/10.1001/jamadermatol.2017.5980
  37. Mendoza JL, García-Paredes J, Peña AS et al. (2003) A continuous spectrum of neutrophilic dermatoses in Crohn’s disease. Rev Esp Enferm Dig 95:233–236,229–232.
  38. Molinelli E, Brisigotti V, Paolinelli M et al. (2021) Novel therapeutic approaches and targets for the treatment of neutrophilic dermatoses, management of patients with neutrophilic dermatoses and future directions in the era of biologic treatment. Curr Pharm Biotechnol 22:46–58. https://doi.org/10.2174/1389201021666200503050803
  39. Mor F, Cohen IR (2013) Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin. Proc Natl Acad Sci USA 110:2981–2986. https://doi.org/10.1073/pnas.1215722110
  40. Nelson CA, Stephen S, Ashchyan HJ et al. (2018) Neutrophilic dermatoses: Pathogenesis, sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. J Am Acad Dermatol 79:987–1006. https://doi.org/10.1016/j.jaad.2017.11.064
  41. Oldfield CW, Heffernan-Stroud LA, Buehler-Bota TS et al. (2016) Bowel-associated dermatosis-arthritis syndrome (BADAS) in a pediatric patient. JAAD Case Rep 2:272–274. https://doi.org/10.1016/j.jdcr.2016.05.012
  42. Richar NA, Bielsa I, Morillas V et al. (2021) Bowel-associated dermatosis–arthritis syndrome (BADAS). Australas J Dermatol 62:241–242. https://doi.org/10.1111/ajd.13516
  43. Russell Johns H, Shetty N, Cash J et al. (2022) Bowel-associated-dermatosis-arthritis syndrome (BADAS) as early presentation of ulcerative colitis in an adolescent girl. Pediatr Dermatol 39:643–645. https://doi.org/10.1111/pde.14954
  44. Shagrin JW, Frame B, Duncan H (1971) Polyarthritis in obese patients with intestinal bypass. Ann Internal Med 75:377–380. https://doi.org/10.7326/0003-4819-75-3-377
  45. Su WPD, Davis MDP, Weenig RH et al. (2004) Pyoderma gangrenosum: Clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43:790–800. https://doi.org/10.1111/j.1365-4632.2004.02128.x
  46. Su WP, Liu HN (1986) Diagnostic criteria for Sweet’s syndrome. Cutis 37:167–174.
  47. Swidsinski A, Weber J, Loening-Baucke V et al. (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43:3380–3389. https://doi.org/10.1128/JCM.43.7.3380-3389.2005
  48. Tharwat S, Eltoraby EE (2020) Pyodermatitis-pyostomatitis vegetans associated with autoimmune hepatitis: Unreported co-existence. Gastroenterol Hepatol Bed Bench 13:188–190.
  49. Truchuelo MT, Alcántara J, Vano-Galván S et al. (2013) Bowel-associated dermatosis-arthritis syndrome: Another cutaneous manifestation of inflammatory intestinal disease. Int J Dermatol 52:1596–1598. https://doi.org/10.1111/j.1365-4632.2011.05149.x
  50. Vázquez J, Almagro M, del Pozo J et al. (2003) Neutrophilic pustulosis and ulcerative colitis. J Eur Acad Dermatol Venereol 17: 77–79. https://doi.org/10.1046/j.1468-3083.2003.00581.x
  51. Verway M, Behr MA, White JH (2010) Vitamin D, NOD2, autophagy and Crohn’s disease. Expert Rev Clin Immunol 6:505–508. https://doi.org/10.1586/eci.10.31
  52. Vich Vila A, Imhann F, Collij V et al. (2018) Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med 10:eaap8914. https://doi.org/10.1126/scitranslmed.aap8914
  53. Yilmaz B, Juillerat P, Øyås O et al. (2019) Microbial network disturbances in relapsing refractory Crohn’s disease. Nat Med 25:323–336. https://doi.org/10.1038/s41591-018-0308-z
Language: English
Submitted on: Sep 10, 2025
|
Accepted on: Nov 21, 2025
|
Published on: Feb 21, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Raman Nitskovich, Aleksandra Jóźwik, Piotr Sobolewski, Paweł Głuszak, Dagmara S. Mahadea, Irena Walecka, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.